Literature DB >> 20654582

Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal.

Jan Albrecht1, Magdalena Zielińska, Michael D Norenberg.   

Abstract

Ammonia is a major neurotoxin implicated in hepatic encephalopathy (HE). Here we discuss evidence that many aspects of ammonia toxicity in HE-affected brain are mediated by glutamine (Gln), synthesized in excess from ammonia and glutamate by glutamine synthetase (GS), an astrocytic enzyme. The degree to which Gln is increased in brains of patients with HE was found to positively correlate with the grade of HE. In animals with HE, a GS inhibitor, methionine sulfoximine (MSO), reversed a spectrum of manifestations of ammonia toxicity, including brain edema and increased intracranial pressure, even though MSO itself increased brain ammonia levels. MSO inhibited, while incubation with Gln reproduced the oxidative stress and cell swelling observed in ammonia-exposed cultured astrocytes. Recent studies have shown that astrocytes swell subsequent to Gln transport into mitochondria and its degradation back to ammonia, which then generates reactive oxygen species and the mitochondrial permeability transition. This sequence of events led to the formulation of the "Trojan Horse" hypothesis. Further verification of the role of Gln in the pathogenesis of HE will have to account for: (1) modification of the effects of Gln by interaction of astrocytes with other CNS cells; and (2) direct effects of Gln on these cells. Recent studies have demonstrated a "Trojan Horse"-like effect of Gln in microglia, as well as an interference by Gln with the activation of the NMDA/NO/cGMP pathway by ammonia as measured in whole brain, a process that likely also involves neurons.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20654582      PMCID: PMC4714775          DOI: 10.1016/j.bcp.2010.07.024

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  74 in total

Review 1.  Oxidative stress in the pathogenesis of hepatic encephalopathy.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 2.  Brain edema in acute liver failure: can it be prevented? Can it be treated?

Authors:  Andres T Blei
Journal:  J Hepatol       Date:  2007-02-05       Impact factor: 25.083

3.  Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy.

Authors:  R Kreis; N Farrow; B D Ross
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

4.  The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine.

Authors:  A Bröer; C A Wagner; F Lang; S Bröer
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

5.  Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure.

Authors:  W Hilgier; M Zielińska; H D Borkowska; R Gadamski; M Walski; S S Oja; P Saransaari; J Albrecht
Journal:  J Neurosci Res       Date:  1999-04-01       Impact factor: 4.164

6.  Analysis of glutamine accumulation in rat brain mitochondria in the presence of a glutamine uptake inhibitor, histidine, reveals glutamine pools with a distinct access to deamidation.

Authors:  E Ziemińska; W Hilgier; H S Waagepetersen; L Hertz; U Sonnewald; A Schousboe; J Albrecht
Journal:  Neurochem Res       Date:  2004-11       Impact factor: 3.996

7.  Inhibition of glutamine transport into mitochondria protects astrocytes from ammonia toxicity.

Authors:  V B R Pichili; K V Rama Rao; A R Jayakumar; M D Norenberg
Journal:  Glia       Date:  2007-06       Impact factor: 7.452

8.  Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure.

Authors:  A Michalak; C Rose; J Butterworth; R F Butterworth
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

9.  Astroglial glutamine transport by system N is upregulated by glutamate.

Authors:  Angelika Bröer; Joachim W Deitmer; Stefan Bröer
Journal:  Glia       Date:  2004-12       Impact factor: 7.452

10.  Glutamine inhibits ammonia-induced accumulation of cGMP in rat striatum limiting arginine supply for NO synthesis.

Authors:  Wojciech Hilgier; Inez Freśko; Emilia Klemenska; Andrzej Beresewicz; Simo S Oja; Pirjo Saransaari; Jan Albrecht; Magdalena Zielińska
Journal:  Neurobiol Dis       Date:  2009-04-18       Impact factor: 5.996

View more
  47 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

Review 2.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

Review 3.  Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives.

Authors:  Milan Holecek
Journal:  Metab Brain Dis       Date:  2013-08-31       Impact factor: 3.584

Review 4.  Management of overt hepatic encephalopathy.

Authors:  Praveen Sharma; Barjesh C Sharma
Journal:  J Clin Exp Hepatol       Date:  2014-05-10

5.  Favorable long-term outcome following severe neonatal hyperammonemic coma in a patient with argininosuccinate synthetase deficiency.

Authors:  Isabelle De Bie; Emmanuelle Lemyre; Marie Lambert
Journal:  JIMD Rep       Date:  2011-06-22

6.  Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders.

Authors:  Alexei Verkhratsky; Vladimir Parpura
Journal:  Neurobiol Dis       Date:  2015-04-03       Impact factor: 5.996

7.  Stratification of astrocytes in healthy and diseased brain.

Authors:  Alexei Verkhratsky; Robert Zorec; Vladimir Parpura
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

Review 8.  Advances in urea cycle neuroimaging: Proceedings from the 4th International Symposium on urea cycle disorders, Barcelona, Spain, September 2013.

Authors:  Ileana Pacheco-Colón; Stanley Fricke; John VanMeter; Andrea L Gropman
Journal:  Mol Genet Metab       Date:  2014-05-20       Impact factor: 4.797

Review 9.  Disaccharides in the treatment of hepatic encephalopathy.

Authors:  Praveen Sharma; Barjesh Chander Sharma
Journal:  Metab Brain Dis       Date:  2013-03-02       Impact factor: 3.584

10.  Brain alanine formation as an ammonia-scavenging pathway during hyperammonemia: effects of glutamine synthetase inhibition in rats and astrocyte-neuron co-cultures.

Authors:  Sherry Dadsetan; Eva Kukolj; Lasse K Bak; Michael Sørensen; Peter Ott; Hendrik Vilstrup; Arne Schousboe; Susanne Keiding; Helle S Waagepetersen
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-15       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.